{"name":"Global Life Science Ventures","permalink":"global-life-science-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/global-life-science-ventures","homepage_url":"http://www.glsv-vc.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+49 (0)89 - 288 151-0","description":"venture capital fund","email_address":"mailbox@glsv-vc.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Sep 16 11:51:09 UTC 2009","updated_at":"Wed Sep 16 11:54:03 UTC 2009","overview":"<p>Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than â‚¬ 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.</p>","image":{"available_sizes":[[[150,57],"assets/images/resized/0005/9922/59922v1-max-150x150.jpg"],[[208,80],"assets/images/resized/0005/9922/59922v1-max-250x250.jpg"],[[208,80],"assets/images/resized/0005/9922/59922v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"HQ","address1":"Von-der-Tann-Str. 3","address2":"","zip_code":"80539","city":"Munchen","state_code":null,"country_code":"DEU","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"e","source_url":"http://deals.venturebeat.com/2007/03/29/coapt-systems-maker-of-aesthetic-surgery-implants-raises-226m-more/","source_description":"Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more","raised_amount":22600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":29,"company":{"name":"Coapt Systems","permalink":"coapt-systems","image":{"available_sizes":[[[80,94],"assets/images/resized/0005/9921/59921v1-max-150x150.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-250x250.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.fiercebiotech.com/story/agendia-closes-23m-series-e-financing/2009-09-23?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Agendia closes $23M Series E financing","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":23,"company":{"name":"Agendia","permalink":"agendia","image":{"available_sizes":[[[100,60],"assets/images/resized/0006/0693/60693v1-max-150x150.png"],[[100,60],"assets/images/resized/0006/0693/60693v1-max-250x250.png"],[[100,60],"assets/images/resized/0006/0693/60693v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"debt_round","source_url":"http://deals.venturebeat.com/2009/12/29/coapt-systems-takes-3-7m-for-facial-rejuvenation/","source_description":"Coapt Systems takes $3.7M for facial rejuvenation","raised_amount":3720000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":29,"company":{"name":"Coapt Systems","permalink":"coapt-systems","image":{"available_sizes":[[[80,94],"assets/images/resized/0005/9921/59921v1-max-150x150.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-250x250.jpg"],[[80,94],"assets/images/resized/0005/9921/59921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.agendia.com/pages/press_release/70.php?aid=47","source_description":"Agendia BV raises $34M and Receives Second FDA Clearance","raised_amount":34000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":28,"company":{"name":"Agendia","permalink":"agendia","image":{"available_sizes":[[[100,60],"assets/images/resized/0006/0693/60693v1-max-150x150.png"],[[100,60],"assets/images/resized/0006/0693/60693v1-max-250x250.png"],[[100,60],"assets/images/resized/0006/0693/60693v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":6390000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":1,"company":{"name":"PIERIS Proteolab","permalink":"pieris-proteolab","image":{"available_sizes":[[[150,104],"assets/images/resized/0004/9781/49781v1-max-150x150.png"],[[199,139],"assets/images/resized/0004/9781/49781v1-max-250x250.png"],[[199,139],"assets/images/resized/0004/9781/49781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/action-pharma-as-series-c-63m/","source_description":"Action Pharma, A/S: Series C $6.3M","raised_amount":6300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":16,"company":{"name":"Action Pharma","permalink":"action-pharma","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120621e86lmuwqs&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120621e86lmuwqs%26from%3dalert%26pid%3d32","source_description":"Denmark's Santaris Grabs $12M From Insiders for Clinical Trials ","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":21,"company":{"name":"Santaris Pharma","permalink":"santaris-pharma","image":{"available_sizes":[[[150,61],"assets/images/resized/0019/6720/196720v1-max-150x150.jpg"],[[161,66],"assets/images/resized/0019/6720/196720v1-max-250x250.jpg"],[[161,66],"assets/images/resized/0019/6720/196720v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}